The agreement will enable health care providers to inject Fluorodeoxyglucose (FDG) for positron emission tomography/computed tomography (PET/CT) imaging procedures in a new way. The partnership will leverage Medrad’s
The Comet trial also showed that 50% of patients taking this Enbrel combination achieved clinical remission and nearly 55% achieved functional remission compared to 28% and 39%, respectively,
The data presented show that GRNCM1 expresses HLA class I antigen on the surface, but not HLA class II, or other surface markers required for T-cell activation, even
The ‘intent to treat’ population of 22 patients included 13 with relapsing remitting multiple sclerosis (RRMS) and nine with secondary progressive multiple sclerosis (SPMS). An analysis of disease
Data from the second cohort of volunteers in a Phase I/IIa clinical trial sponsored by the US Naval Medical Research Center (NMRC) and the US Military Malaria Vaccine
The agent, CTC-96, also known as Doxovir, was developed by Redox Pharmaceutical. CTC-96’s novel antiviral mechanism has demonstrated efficacy against multiple viral infections in preclinical studies. CTC-96 has
The shares of common stock and warrants were offered in units consisting of one share of common stock and a warrant to purchase 0.20 shares of common stock
Mazal Plant Pharmaceuticals has also received approval to conduct a large-scale, double-blind, four-arm study in human subjects diagnosed with alphalipoproteinemia (subjects with low HDL). The subjects will be
Advanced Medical Isotope (AMIC) proposes development of a proprietary concept for controlled delivery of yttrium-90 (Y-90) microspheres embedded in resorbable seed-shape materials for tissue-directed, high-dose intra-tumoral therapy. According
Atlas was a randomized, placebo-controlled, double-blind, Phase III study conducted in the US and Europe. The study involved 315 patients with active ankylosing spondylitis (AS) who had an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.